Jonathan Broner
Impact in
- Rheumatology top 10%
- Otitis Media and Relapsing Polychondritis
-
- Vascular Anomalies and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Otitis Media and Relapsing Polychondritis 5
- Urticaria and Related Conditions 2
-
- Vasculitis and related conditions 11
- Co-authors
- Radjiv Goulabchand (7 shared papers)Cécile Gaujoux-Viala (1 shared paper)Thibault Mura (1 shared paper)C. Roubille (2 shared papers)Albert Sotto (1 shared paper)Antonia Pérez‐Martin (1 shared paper)Ilan Szwarc (1 shared paper)Jean‐Emmanuel Serre (1 shared paper)
In The Last Decade
Jonathan Broner
27 papers receiving 305 citations
Peers
Comparison fields: 5 of 31
- Rheumatology 148
- Genetics 60
- Hematology 60
- Nephrology 24
- Pulmonary and Respiratory Medicine 91
Countries citing papers authored by Jonathan Broner
This map shows the geographic impact of Jonathan Broner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Broner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Broner more than expected).
Fields of papers citing papers by Jonathan Broner
This network shows the impact of papers produced by Jonathan Broner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Broner. The network helps show where Jonathan Broner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Broner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 47 | |
| 2 | 2024 | 42 | |
| 3 | 2021 | 35 | |
| 4 | 2017 | 29 | |
| 5 | 2020 | 29 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 16 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2023 | 8 | |
| 12 | 2019 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2017 | 2 |
About Jonathan Broner
Jonathan Broner is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Genetics, Hematology and Immunology, having authored 32 papers that have together received 307 indexed citations. Recurring topics across this work include Vasculitis and related conditions (11 papers), Otitis Media and Relapsing Polychondritis (5 papers), Platelet Disorders and Treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Renal Diseases and Glomerulopathies (2 papers), Urticaria and Related Conditions (2 papers), Hemophilia Treatment and Research (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Rheumatology (148 citations), Genetics (60 citations), Hematology (60 citations), Nephrology (24 citations) and Pulmonary and Respiratory Medicine (91 citations). Jonathan Broner has collaborated with scholars based in France, Italy and Morocco. Frequent co-authors include Radjiv Goulabchand, Cécile Gaujoux-Viala, Thibault Mura, C. Roubille, Albert Sotto, Antonia Pérez‐Martin, Ilan Szwarc, Jean‐Emmanuel Serre, Vincent Pernin and E. Mousty. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Haematologica, JAMA Network Open and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.